Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-110383
Filing Date
2025-11-12
Accepted
2025-11-12 16:16:13
Documents
76
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20250930x10q.htm   iXBRL 10-Q 1544766
2 EX-31.1 armp-20250930xex31d1.htm EX-31.1 15690
3 EX-31.2 armp-20250930xex31d2.htm EX-31.2 15289
4 EX-32.1 armp-20250930xex32d1.htm EX-32.1 7939
5 EX-32.2 armp-20250930xex32d2.htm EX-32.2 8371
6 GRAPHIC armp-20250930x10q001.jpg GRAPHIC 54059
  Complete submission text file 0001104659-25-110383.txt   6969041

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20250930.xsd EX-101.SCH 45822
8 EX-101.CAL armp-20250930_cal.xml EX-101.CAL 51239
9 EX-101.DEF armp-20250930_def.xml EX-101.DEF 182806
10 EX-101.LAB armp-20250930_lab.xml EX-101.LAB 406387
11 EX-101.PRE armp-20250930_pre.xml EX-101.PRE 325655
79 EXTRACTED XBRL INSTANCE DOCUMENT armp-20250930x10q_htm.xml XML 1154910
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 251472968
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)